Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7325471rdf:typepubmed:Citationlld:pubmed
pubmed-article:7325471lifeskim:mentionsumls-concept:C1280551lld:lifeskim
pubmed-article:7325471lifeskim:mentionsumls-concept:C0031327lld:lifeskim
pubmed-article:7325471lifeskim:mentionsumls-concept:C0027396lld:lifeskim
pubmed-article:7325471pubmed:issue9lld:pubmed
pubmed-article:7325471pubmed:dateCreated1982-3-13lld:pubmed
pubmed-article:7325471pubmed:abstractTextThe pharmacokinetics of naproxen was studied in mongrel dogs. After IV injection of a 5 mg/kg dose, plasma concentrations decreased biexponentially, with an average elimination half-life of 74 hours. The drug was highly protein-bound (greater than 99%) and had a correspondingly low apparent volume of distribution (0.13 L/kg). After naproxen was given orally, absorption was rapid, and the bioavailability ranged between 68% and 100%. With an initial dose of 5 mg/kg given orally, therapeutic plasma concentrations could be maintained by giving 1 daily dose of 1.2 to 2.8 mg/kg.lld:pubmed
pubmed-article:7325471pubmed:languageenglld:pubmed
pubmed-article:7325471pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7325471pubmed:citationSubsetIMlld:pubmed
pubmed-article:7325471pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7325471pubmed:statusMEDLINElld:pubmed
pubmed-article:7325471pubmed:monthSeplld:pubmed
pubmed-article:7325471pubmed:issn0002-9645lld:pubmed
pubmed-article:7325471pubmed:authorpubmed-author:FreyH HHHlld:pubmed
pubmed-article:7325471pubmed:authorpubmed-author:RiehBBlld:pubmed
pubmed-article:7325471pubmed:issnTypePrintlld:pubmed
pubmed-article:7325471pubmed:volume42lld:pubmed
pubmed-article:7325471pubmed:ownerNLMlld:pubmed
pubmed-article:7325471pubmed:authorsCompleteYlld:pubmed
pubmed-article:7325471pubmed:pagination1615-7lld:pubmed
pubmed-article:7325471pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7325471pubmed:meshHeadingpubmed-meshheading:7325471-...lld:pubmed
pubmed-article:7325471pubmed:meshHeadingpubmed-meshheading:7325471-...lld:pubmed
pubmed-article:7325471pubmed:meshHeadingpubmed-meshheading:7325471-...lld:pubmed
pubmed-article:7325471pubmed:meshHeadingpubmed-meshheading:7325471-...lld:pubmed
pubmed-article:7325471pubmed:meshHeadingpubmed-meshheading:7325471-...lld:pubmed
pubmed-article:7325471pubmed:meshHeadingpubmed-meshheading:7325471-...lld:pubmed
pubmed-article:7325471pubmed:meshHeadingpubmed-meshheading:7325471-...lld:pubmed
pubmed-article:7325471pubmed:year1981lld:pubmed
pubmed-article:7325471pubmed:articleTitlePharmacokinetics of naproxen in the dog.lld:pubmed
pubmed-article:7325471pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7325471pubmed:publicationTypeComparative Studylld:pubmed